genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2014
Santaris Pharma
Industry News
Roche Acquiring Santaris Pharma for Up to $450M
News
Santaris Resumes Full LNA Ownership as Enzon Collaboration Ends
News
BMS, Santaris Make Potentially $100M+ mRNA-Targeting Deal
News
Santaris Pharma Licenses miRNA from MGH for Development in Cardiovascular Diseases
News
Pfizer Pays $14M to Expand RNA Partnership with Santaris Pharma
News
Santaris Receives Minority miRagen Stake through Cardiovascular Therapeutics Deal
Insights
Chasing the Therapeutic Potential of miRNAs
News
Santaris Pharma Consortium Receives $9.33M to Develop RNA Drug Compounds
News
Enzon and Santaris to Collaborate on Novel Cancer Drugs
Scroll Up
Scroll Up
